A Randomized Trial of GM-CSF in Patients With ALI/ARDS

Clinical Trial ID NCT00201409

Rank	Title	Journal	Year	PubWeight™‹?›
1	A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction.	Am J Respir Crit Care Med	2002	2.05
2	Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome.	Crit Care Med	2000	2.04
3	A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury.	Crit Care Med	2012	1.92
4	Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation.	Eur Respir J	2012	1.46
5	Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome.	Nat Microbiol	2016	1.43
6	Sublethal hyperoxia impairs pulmonary innate immunity.	J Immunol	2003	1.34
7	Impaired functional activity of alveolar macrophages from GM-CSF-deficient mice.	Am J Physiol Lung Cell Mol Physiol	2001	1.33
8	Transgenic overexpression of granulocyte macrophage-colony stimulating factor in the lung prevents hyperoxic lung injury.	Am J Pathol	2003	1.18